发明授权
US06344455B1 N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, and irreversible inhibitor of tyrosine kinases
失效
N- [4-(3-氯-4-氟 - 苯基氨基)-7-(3-吗啉-4-基 - 丙氧基) - 喹唑啉-6-基] - 丙烯酰胺和酪氨酸激酶的不可逆抑制剂
- 专利标题: N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, and irreversible inhibitor of tyrosine kinases
- 专利标题(中): N- [4-(3-氯-4-氟 - 苯基氨基)-7-(3-吗啉-4-基 - 丙氧基) - 喹唑啉-6-基] - 丙烯酰胺和酪氨酸激酶的不可逆抑制剂
-
申请号: US09831991申请日: 2001-05-16
-
公开(公告)号: US06344455B1公开(公告)日: 2002-02-05
- 发明人: Alexander James Bridges , Denise Driscoll , Wayne Daniel Klohs
- 申请人: Alexander James Bridges , Denise Driscoll , Wayne Daniel Klohs
- 主分类号: A61K315377
- IPC分类号: A61K315377
摘要:
This invention relates to the compound N-[4-(3-chloro4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide that is an irreversible inhibitor of tyrosine kinases. This invention also relates to a method of treating cancer, atherosclerosis, restenosis, endometriosis, and psoriasis using the compound N-[4-(3-chloro4-fluoro-phenylamino)-7-(3-morpholin4-yl-propoxy)-quinazolin-6-yl]-acrylamide, and to a pharmaceutical composition that comprises the compound N-[4-(3-chloro4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide.
信息查询